Atosiban Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Atosiban Atosiban Inhouse Impurity B VE008049View CAS 960411-86-3

[rfq_list]

Request a quote

960411-86-3: Atosiban Inhouse Impurity B

960411-86-3: Atosiban Inhouse Impurity B
Catalogue No.

VE008049

CAS No.

960411-86-3

Molecular Formula

C43H69N11O12S2

Molecular Weight

996.2 g/mol

Parent drug

Atosiban

IUPAC Name

(2S)-N1-((2R)-1-((2S)-2-((5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-3-mercapto-1-oxopropan-2-yl)-2-((2S, 3R)-2-((2S, 3S)-2-((R)-3-(4-ethoxyphenyl)-2-(3-mercaptopropanamido)propanamido)-3-methylpentanamido)-3-hydroxybutanamido)succinamide

Synonyms

N/A

References

Buddhabunyakan, Nattapong, et al. “Effects of Atosiban on Uterine Peristalsis Following Frozen Embryo Transfer: A Randomized Controlled Trial.” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 265, Oct. 2021, pp. 96–101, https://doi.org/10.1016/j.ejogrb.2021.08.017.

Status

In-stock

ListName

Atosiban Inhouse Impurity B

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden